NCT02431624View on ClinicalTrials.gov

An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

November 30, 2015

Conditions
Pain
Interventions
DRUG

BTDS

Trial Locations (1)

Unknown

BioKinetic Europe Ltd, Belfast

All Listed Sponsors
lead

Mundipharma Research Limited

INDUSTRY

NCT02431624 - An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion | Biotech Hunter | Biotech Hunter